Outset Medical (OM) Cash from Financing Activities (2019 - 2026)

Outset Medical (OM) has 8 years of Cash from Financing Activities data on file, last reported at $501000.0 in Q1 2026.

• On a quarterly basis, Cash from Financing Activities fell 99.1% year-over-year to $501000.0 in Q1 2026; TTM through Mar 2026 was $348000.0, a 99.37% decrease from a year earlier, with the FY2025 full-year figure at $55.5 million, down 18.22% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at $501000.0, up from $231000.0 in the prior quarter.
• Over the last five years, Cash from Financing Activities for OM reached as high as $68.6 million in Q1 2024 and fell as low as -$938000.0 in Q4 2024.
• Historically, Cash from Financing Activities has averaged $15.0 million across 5 years, with a median of $1.8 million in 2022.
• Across the five-year window, Cash from Financing Activities soared 6923.55% in 2022 and slumped 598.7% in 2025, its largest moves.
• Year by year, Cash from Financing Activities stood at $65.6 million in 2022, then plunged by 49.35% to $33.2 million in 2023, then sank by 102.82% to -$938000.0 in 2024, then soared by 124.63% to $231000.0 in 2025, then jumped by 116.88% to $501000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were $501000.0 in Q1 2026, $231000.0 in Q3 2025, and -$384000.0 in Q2 2025.